Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 193

1.

Cost-effectiveness of TNF inhibitors vs synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: a Markov model study based on two longitudinal observational studies.

Kvamme MK, Lie E, Uhlig T, Moger TA, Kvien TK, Kristiansen IS.

Rheumatology (Oxford). 2015 Jan 7. pii: keu460. [Epub ahead of print]

PMID:
25573840
2.

Real life cost and quality of life associated with continuous intraduodenal levodopa infusion compared with oral treatment in Parkinson patients.

Lundqvist C, Beiske AG, Reiertsen O, Kristiansen IS.

J Neurol. 2014 Dec;261(12):2438-45. doi: 10.1007/s00415-014-7515-4. Epub 2014 Oct 1.

PMID:
25270681
3.

Re: Hvorfor blir jeg ikke sitert?

Kristiansen IS.

Tidsskr Nor Laegeforen. 2014 Sep 2;134(16):1547. doi: 10.4045/tidsskr.14.0915. eCollection 2014 Sep 2. Norwegian. No abstract available.

PMID:
25178212
Free Article
4.

Too late to vaccinate? The incremental benefits and cost-effectiveness of a delayed catch-up program using the 4-valent human papillomavirus vaccine in Norway.

Burger EA, Sy S, Nygård M, Kristiansen IS, Kim JJ.

J Infect Dis. 2015 Jan 15;211(2):206-15. doi: 10.1093/infdis/jiu413. Epub 2014 Jul 23.

PMID:
25057044
5.

Health-related quality of life after myocardial infarction, does choice of method make a difference?

Bøhmer E, Kristiansen IS, Arnesen H, Halvorsen S.

Scand Cardiovasc J. 2014 Aug;48(4):216-22. doi: 10.3109/14017431.2014.923581. Epub 2014 Jun 26.

PMID:
24828790
6.

Does the primary screening test influence women's anxiety and intention to screen for cervical cancer? A randomized survey of Norwegian women.

Burger EA, Nygård M, Gyrd-Hansen D, Moger TA, Kristiansen IS.

BMC Public Health. 2014 Apr 15;14:360. doi: 10.1186/1471-2458-14-360.

7.

Communicating risk using absolute risk reduction or prolongation of life formats: cluster-randomised trial in general practice.

Harmsen CG, Kristiansen IS, Larsen PV, Nexøe J, Støvring H, Gyrd-Hansen D, Nielsen JB, Edwards A, Jarbøl DE.

Br J Gen Pract. 2014 Apr;64(621):e199-207. doi: 10.3399/bjgp14X677824.

8.

Prevention of HPV-related cancers in Norway: cost-effectiveness of expanding the HPV vaccination program to include pre-adolescent boys.

Burger EA, Sy S, Nygård M, Kristiansen IS, Kim JJ.

PLoS One. 2014 Mar 20;9(3):e89974. doi: 10.1371/journal.pone.0089974. eCollection 2014.

9.

Trends in breast cancer stage distribution before, during and after introduction of a screening programme in Norway.

Lousdal ML, Kristiansen IS, Møller B, Støvring H.

Eur J Public Health. 2014 Dec;24(6):1017-22. doi: 10.1093/eurpub/cku015. Epub 2014 Mar 4.

PMID:
24596400
10.

Dynamic modeling of cost-effectiveness of rotavirus vaccination, Kazakhstan.

Freiesleben de Blasio B, Flem E, Latipov R, Kuatbaeva A, Kristiansen IS.

Emerg Infect Dis. 2014 Jan;20(1):29-37. doi: 10.3201/eid2001.130019.

11.

Cost and health consequences of treatment of primary biliary cirrhosis with ursodeoxycholic acid.

Boberg KM, Wisløff T, Kjøllesdal KS, Støvring H, Kristiansen IS.

Aliment Pharmacol Ther. 2013 Oct;38(7):794-803. doi: 10.1111/apt.12435. Epub 2013 Aug 5.

PMID:
23915021
12.

What professional activities do general practitioners find most meaningful? Cross sectional survey of Norwegian general practitioners.

Halvorsen PA, Edwards A, Aaraas IJ, Aasland OG, Kristiansen IS.

BMC Fam Pract. 2013 Mar 23;14:41. doi: 10.1186/1471-2296-14-41.

13.

[The challenges of subject criticism].

Olsen JA, Kristiansen IS, Magnussen J, Norheim OF, Robberstad B.

Tidsskr Nor Laegeforen. 2013 Mar 5;133(5):499. doi: 10.4045/tidsskr.13.0174. Norwegian. No abstract available.

14.
15.

Dynamic modelling of costs and health consequences of school closure during an influenza pandemic.

Xue Y, Kristiansen IS, de Blasio BF.

BMC Public Health. 2012 Nov 9;12:962. doi: 10.1186/1471-2458-12-962.

16.

Impact of transformation of negative values and regression models on differences between the UK and US EQ-5D time trade-off value sets.

Augestad LA, Rand-Hendriksen K, Kristiansen IS, Stavem K.

Pharmacoeconomics. 2012 Dec 1;30(12):1203-14. doi: 10.2165/11595420-000000000-00000.

PMID:
23116290
17.

Cost-effectiveness of supplementing a broth-enriched culture test with the Xpert meticillin-resistant Staphylococcus aureus (MRSA) assay for screening inpatients at high risk of MRSA.

Li J, Ulvin K, Biboh H, Kristiansen IS.

J Hosp Infect. 2012 Dec;82(4):227-33. doi: 10.1016/j.jhin.2012.08.009. Epub 2012 Oct 23.

PMID:
23098683
18.

Medication effectiveness may not be the major reason for accepting cardiovascular preventive medication: a population-based survey.

Harmsen CG, Støvring H, Jarbøl DE, Nexøe J, Gyrd-Hansen D, Nielsen JB, Edwards A, Kristiansen IS.

BMC Med Inform Decis Mak. 2012 Aug 9;12:89. doi: 10.1186/1472-6947-12-89.

19.

Maternal preference for cesarean delivery: do women get what they want?

Fuglenes D, Aas E, Botten G, Øian P, Kristiansen IS.

Obstet Gynecol. 2012 Aug;120(2 Pt 1):252-60. doi: 10.1097/AOG.0b013e3182605b1a.

PMID:
22825082
20.

Time trade-off and attitudes toward euthanasia: implications of using 'death' as an anchor in health state valuation.

Augestad LA, Rand-Hendriksen K, Stavem K, Kristiansen IS.

Qual Life Res. 2013 May;22(4):705-14. doi: 10.1007/s11136-012-0192-9. Epub 2012 Jun 8.

PMID:
22678351
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk